- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Particle Works offers bespoke microencapsulation for drug development
12 October 2016 • Author: Particle Works
Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery.
Using its expertise in microfluidics and nanoparticle synthesis, the company can create bespoke PLGA formulations and coatings to alter drug release profiles, enhance the efficiency of targeted drug delivery and more precisely control dosing regimes.
Microencapsulation of active pharmaceutical ingredients (APIs) is increasingly being employed in the drug development arena to improve the solubility of candidate drugs or protect biopharmaceutical agents (DNA, proteins, etc) from degradation, as well as to provide more controlled release of APIs over time. Functionalization of the particle surfaces with specific binding species – such as antibodies, aptamers and peptides – also allows the particles to be targeted to a specific location or tissue, increasing the efficacy of many drugs. PLGA is commonly used for drug microencapsulation, and precise control over particle size, shape and architecture is extremely important to the efficacy of the candidate drug. Particle Works can use its expertise in nanoparticle development to improve the targeting efficiency, distribution and lifetime of the particles in vivo. From the encapsulation of candidate APIs in custom PLGA configurations to the creation of unique functionalized coatings, the company can provide high quality development and scale-up of highly monodisperse nanoparticles (typical CV values of <5 %) offering improved targeting efficiency, efficacy and reproducibility.
For more information, visit: http://www.particle-works.com/applications/targeted-drug-delivery/
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics